Market Newsdesk

TORONTO, April 04, 2025 (GLOBE NEWSWIRE) — Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) today announced that the Company has sold 1,000,000 common shares (the “Common Shares”) of American Copper Development Corporation (“American Copper”) at a price of C$0.1607 per Common Share for aggregate consideration of C$160,710 (the “Transaction”) and has filed an early warning report in respect of the Transaction.

Immediately prior to the Transaction, Hudbay held 1,979,319 Common Shares of American Copper, which represented approximately 10.7% of American Copper’s currently issued and outstanding Common Shares. Following closing of the Transaction, Hudbay will own 979,319 Common Shares, which represents approximately 5.3% of American Copper’s currently issued and outstanding Common Shares.

This news release is issued pursuant to applicable Canadian securities laws, including the requirements of National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues. A copy of the corresponding early warning report will be filed and be available on American Copper’s profile on SEDAR+ at www.sedarplus.ca. The head office of American Copper is located at 710-1030 West Georgia Street, Vancouver, British Columbia, V6E 2Y3. The head office of Hudbay is located at 25 York Street, Suite 800, Toronto, Ontario, M5J 2V5.

Forward-Looking Information

This news release contains “forward-looking statements” and “forward-looking information” (collectively, “forward-looking information”) within the meaning of applicable Canadian and United States securities legislation. Forward- looking information includes information that relates to, among other things, statements with respect to the disposition of American Copper Common Shares. Forward-looking information is not, and cannot be, a guarantee of future results or events.

Forward-looking information is based on, among other things, opinions, assumptions, estimates and analyses that, while considered reasonable by Hudbay at the date the forward-looking information is provided, inherently are subject to significant risks, uncertainties, contingencies and other factors that may cause actual results and events to be materially different from those expressed or implied by the forward-looking information. Should one or more risk, uncertainty, contingency or other factor materialize or should any factor or assumption prove incorrect, actual results could vary materially from those expressed or implied in the forward-looking information. Hudbay does not assume any obligation to update or revise any forward-looking information after the date of this news release or to explain any material difference between subsequent actual events and any forward-looking information, except as required by applicable law.

About Hudbay

Hudbay (TSX, NYSE: HBM) is a copper-focused critical minerals company with three long-life operations and a world-class pipeline of copper growth projects in tier-one mining jurisdictions of Canada, Peru and the United States.

Hudbay’s operating portfolio includes the Constancia mine in Cusco (Peru), the Snow Lake operations in Manitoba (Canada) and the Copper Mountain mine in British Columbia (Canada). Copper is the primary metal produced by the company, which is complemented by meaningful gold production and by-product zinc, silver and molybdenum. Hudbay’s growth pipeline includes the Copper World project in Arizona (United States), the Mason project in Nevada (United States), the Llaguen project in La Libertad (Peru) and several expansion and exploration opportunities near its existing operations.

The value Hudbay creates and the impact it has is embodied in its purpose statement: “We care about our people, our communities and our planet. Hudbay provides the metals the world needs. We work sustainably, transform lives and create better futures for communities.” Hudbay’s mission is to create sustainable value and strong returns by leveraging its core strengths in community relations, focused exploration, mine development and efficient operations.

For further information, please contact:

Candace Brûlé
Vice President, Investor Relations, Financial Analysis and External Communications
(416) 814-4387
[email protected]

DALLAS, April 04, 2025 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on April 1, 2025, the Compensation Committee of Taysha’s Board of Directors granted five new employees, in the aggregate, options to purchase 822,000 shares of the Company’s common stock in connection with their employment. The stock options were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).

The stock options have an exercise price of $1.265 which is equal to the closing price of Taysha’s common stock on the date of grant. The stock option has a 10-year term and will vest over four years, with 25% of the option vesting on the first anniversary of the vesting commencement date and the remaining 75% of the option vesting in equal monthly installments over the 36 months thereafter. Vesting of the stock option is subject to such employee’s continued service to Taysha on each vesting date.

About Taysha Gene Therapies

Taysha Gene Therapies (Nasdaq: TSHA) is a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system. Its lead clinical program TSHA-102 is in development for Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. With a singular focus on developing transformative medicines, Taysha aims to address severe unmet medical needs and dramatically improve the lives of patients and their caregivers. The Company’s management team has proven experience in gene therapy development and commercialization. Taysha leverages this experience, its manufacturing process and a clinically and commercially proven AAV9 capsid in an effort to rapidly translate treatments from bench to bedside. For more information, please visit http://www.tayshagtx.com.

Company Contact:

Hayleigh Collins
Senior Director, Corporate Communications and Investor Relations
Taysha Gene Therapies, Inc.
[email protected]

Media Contact:

Carolyn Hawley
Inizio Evoke
[email protected]

BOCA RATON, Fla., April 04, 2025 (GLOBE NEWSWIRE) — FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading provider of real-time information solutions for real estate agents, today announced that Little Rock REALTORS^® Association (“LRRA”) will offer FOREWARN^® services to its 1,400+ members it serves throughout the Little Rock metropolitan area to promote proactive real estate agent safety.

Available both online and through a mobile application, FOREWARN analyzes billions of data points and provides users with the ability to mitigate risks by verifying identity, searching for criminal histories, and validating information provided by potential clients — using just a phone number. FOREWARN allows agents to properly and safely plan for showings with a higher level of confidence.

The FOREWARN services offered by LRRA are available to the 1,400+ members at no additional cost to individual agents.

“It’s exciting that my home Association has made this investment into the safety of our members,” stated Carl Carter, a Little Rock REALTORS^® Association member. “As a community still shaken by the tragic loss of my mom, Beverly Carter, providing access to FOREWARN further empowers agents to conduct their business in the safest way possible. I’ve been a FOREWARN user for several years now and have seen firsthand its transformative impact on how agents conduct their business and reinforcing the importance of consistent, informed workflows. As I’ve traveled the country speaking on agent safety, I’ve heard many stories from agents expressing gratitude for FOREWARN providing information they believe helped keep them safe. I’m so thankful the Little Rock REALTOR Association has brought this amazing resource to our agent family.”

Stacy Hamilton, CEO of Little Rock REALTORS^® Association, added “Our top priority is ensuring the safety and success of our members by providing them with the most effective tools available. With the ever-present risks in the industry, providing FOREWARN was a clear choice. Having instant access to advanced identity verification empowers our members to make informed decisions, enhancing both their security and confidence in every interaction.”

Existing LRRA members will receive specific instructions on how to move forward with activating their FOREWARN subscription as an included benefit.

All other real estate agencies, agents, and appraisers can learn more about FOREWARN at www.forewarn.com.

About FOREWARN^®

At FOREWARN, we bring instant knowledge through innovative solutions to ensure safer engagements and smarter interactions. Leveraging powerful analytics and a massive data repository, our solutions enable organizations to gain real-time knowledge, for purposes such as verifying identity, searching for criminal histories, and validating information. Risk assessment and due diligence at your fingertips™.

RELATED LINKS:

www.forewarn.com

About red violet^®

At red violet, we build proprietary technologies and apply analytical capabilities to deliver identity intelligence. Our technology powers critical solutions, which empower organizations to operate with confidence. Our solutions enable the real-time identification and location of people, businesses, assets and their interrelationships. These solutions are used for purposes including identity verification, risk mitigation, due diligence, fraud detection and prevention, regulatory compliance, and customer acquisition. Our intelligent platform, CORE™, is purpose-built for the enterprise, yet flexible enough for organizations of all sizes, bringing clarity to massive datasets by transforming data into intelligence. Our solutions are used today to enable frictionless commerce, to ensure safety, and to reduce fraud and the concomitant expense borne by society. For more information, please visit www.redviolet.com.

FORWARD-LOOKING STATEMENTS

This press release contains “forward-looking statements,” as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA), which statements may be identified by words such as “expects,” “plans,” “projects,” “will,” “may,” “anticipate,” “believes,” “should,” “intends,” “estimates,” and other words of similar meaning. Such forward looking statements are subject to risks and uncertainties that are often difficult to predict, are beyond our control and which may cause results to differ materially from expectations, including whether FOREWARN will address critical safety and security areas for Little Rock REALTORS^® Association members and whether FOREWARN will give Little Rock REALTORS^® Association members to make informed decisions, enhancing both their security and confidence in every interaction. Readers are cautioned not to place undue reliance on these forward-looking statements, which are based on our expectations as of the date of this press release and speak only as of the date of this press release and are advised to consider the factors listed above together with the additional factors under the heading “Forward-Looking Statements” and “Risk Factors” in red violet’s SEC Filings. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

Investor Relations Contact:

Camilo Ramirez
Red Violet, Inc.
561-757-4500
[email protected]

FRAMINGHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) — Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior leader, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted inducement awards. The Committee granted Jeff Moyer, Definitive Healthcare’s new SVP of Growth and Sales Operations, an inducement award consisting of 364,432 time-based restricted stock units (“RSUs”), effective April 3, 2025. These awards were individually negotiated and granted as an inducement material to Mr. Moyer’s respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).

Each of the awards is subject to the terms and conditions of Definitive Healthcare’s 2023 Inducement Plan (the “Plan”) and the terms and conditions of an applicable award agreement covering the grant.

Mr. Moyer’s RSUs will vest as follows, subject to Mr. Moyer’s continued employment through each such date: (i) 25% will vest on April 1, 2026; (ii) the remainder will vest in quarterly installments equal to 6.25% of the total RSUs over the subsequent 3 years, until fully vested.

About Definitive Healthcare

At Definitive Healthcare, our passion is to transform data, analytics, and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities, and people, so they can shape tomorrow’s healthcare industry. Our SaaS platform creates new paths to commercial success in the healthcare market, so companies can identify where to go next. Learn more at definitivehc.com.

Investor Contact:

Brian Denyeau
ICR for Definitive Healthcare
[email protected]
646-277-1251

Media Contact:

Bethany Swackhamer
[email protected]

HOUSTON, April 04, 2025 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) is excited to announce the grand opening of two new communities in the Houston area: Canterra Creek in Iowa Colony and Trails at Cochran Ranch in Waller. Both communities offer a selection of newly constructed homes with built-in upgrades, providing an affordable and convenient path to homeownership in desirable locations.

Canterra Creek – Iowa Colony, TX

Located just 15 miles from Pearland, Canterra Creek offers homebuyers a choice of spacious three- and four-bedroom homes, ranging from 1,375 to 2,339 square feet. With both one- and two-story floor plans available, each home comes with LGI Homes’ CompleteHome™ package, featuring a range of high-quality upgrades such as granite countertops, stainless steel Whirlpool® kitchen appliances, designer wood cabinetry, luxury vinyl-plank flooring and Wi-Fi-enabled garage door openers—all included in the base price.

Canterra Creek is designed with families in mind, offering a wealth of amenities for residents to enjoy. The community will feature a lazy river, multiple pools, splash pads, sports courts, and exercise facilities. Additionally, scenic walking trails provide residents with ample options for outdoor activities. Canterra Creek is also conveniently located near Highway 288, ensuring quick access to Houston’s major employers, shopping, dining and entertainment options.

“Minutes from the Med Center and Manvel Town Center, Canterra Creek offers incredible value,” stated Zach Walden, VP of Operations for Houston. “The community’s amenity center, slated to open this summer, includes a pool, pickleball courts and fitness center.”

Homes at Canterra Creek start in the $290s, with move-in ready homes available. To learn more or schedule a tour, interested buyers can call (866) 764-8973 ext. 350.

Trails at Cochran Ranch – Waller, TX

Located in Waller, Texas, Trails at Cochran Ranch offers affordable three- and four-bedroom homes designed with open-concept layouts. Each home comes with LGI Homes’ CompleteHome™ package, which includes upgrades like stainless steel kitchen appliances, granite countertops, luxury vinyl plank flooring, and energy-efficient windows included.

“With Waller being one of the fastest growing areas in metro Houston, we are excited to open Trails at Cochran Ranch offering affordable, new single-family homes on spacious lots,” stated Walden.

The community boasts a variety of family-friendly amenities, including a community park, playground, pavilion, and scenic walking trails. Trails at Cochran Ranch is situated near the heart of Waller, providing residents with proximity to local shopping, dining, and entertainment options, as well as excellent schools. With its welcoming neighborhood atmosphere, this community is perfect for families looking to settle in a well-connected area.

Homes at Trails at Cochran Ranch start from the low-$200s, with move-in ready opportunities available. For more information or to schedule a tour, interested buyers can call (855) 958-4517 ext. 350.

About LGI Homes

Headquartered in The Woodlands, Texas, LGI Homes, Inc. is a pioneer in the homebuilding industry, successfully applying an innovative and systematic approach to the design, construction and sale of homes across 36 markets in 21 states. As one of America’s fastest growing companies, LGI Homes has closed over 75,000 homes since its founding in 2003 and has delivered profitable financial results every year. Nationally recognized for its quality construction and exceptional customer service, LGI Homes was named to Newsweek’s list of the World’s Most Trustworthy Companies. LGI Homes’ commitment to excellence extends to its more than 1,000 employees, earning the Company numerous workplace awards at the local, state and national level, including the Top Workplaces USA 2024 Award. For more information about LGI Homes and its unique operating model focused on making the dream of homeownership a reality for families across the nation, please visit the Company’s website at www.lgihomes.com.

MEDIA CONTACT:

Rachel Eaton
(281) 362-8998 ext. 2560

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/9632bdd3-c7e8-4fa4-af24-37e506df0844

WAYNE, Pa., April 04, 2025 (GLOBE NEWSWIRE) — (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no Food and Drug Administration (FDA)-approved therapies, today announced that Wes Kaupinen, Founder and Chief Executive Officer of Palvella will participate in a fireside chat at the Jones Healthcare and Technology Innovation Conference on Wednesday, April 9, 2025, at 2:00 p.m. PT.

A live webcast of the fireside chat will be available on the Events and Presentations section of Palvella’s website at www.palvellatx.com. An archived replay of the webcast will be available for approximately 90 days following the presentation.

About Palvella Therapeutics

Founded and led by rare disease drug development veterans, Palvella Therapeutics, Inc. (Nasdaq: PVLA) is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. Palvella is developing a broad pipeline of product candidates based on its patented QTORIN™ platform, with an initial focus on serious, rare genetic skin diseases, many of which are lifelong in nature. Palvella’s lead product candidate, QTORIN 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin), is currently being evaluated in the Phase 3 SELVA clinical trial in microcystic lymphatic malformations and the Phase 2 TOIVA clinical trial in cutaneous venous malformations. For more information, please visit www.palvellatx.com or follow Palvella on LinkedIn or X (formerly known as Twitter).

QTORIN™ rapamycin is for investigational use only and has not been approved or cleared by the FDA or by any other regulatory agency for any indication.

Contact Information

Investors

Wesley H. Kaupinen
Founder and CEO, Palvella Therapeutics
[email protected]

Media

Marcy Nanus
Managing Partner, Trilon Advisors, LLC
[email protected]

MIAMI, April 04, 2025 (GLOBE NEWSWIRE) — OPKOHealth,Inc.(NASDAQ:OPK) today announced that its Board of Directors has authorized an increase of $100 million to the Company’s existing common stock repurchase program, bringing the aggregate capacity of the program to $200 million. Approximately $41 million of OPKO’s common stock has been repurchased under the existing program since its authorization in July 2024.

“We believe OPKO’s shares continue to be significantly undervalued and offer an attractive investment opportunity. Buying back shares supports our conviction in OPKO’s strategy as we continue to advance our pipeline in the clinic and streamline our diagnostic segment on a path to profitability,” said Phillip Frost, M.D., Chairman and Chief Executive Officer of OPKO. “Our strong cash position provides the ability to continue to fund our programs, while returning capital to our shareholders.”

OPKO intends to repurchase shares of its common stock from time to time through open market purchases, block trades, privately negotiated transactions, accelerated share repurchase transactions and/or pursuant to Rule 10b5-1 plans, in compliance with applicable securities laws and other legal requirements. The timing and amount of any repurchases will be subject to general market conditions, as well as the Company’s management of capital, other investment opportunities and other factors. The repurchase program does not obligate the Company to repurchase any specific number of shares, has no time limit and may be modified, suspended or discontinued at any time at the Company’s discretion.

OPKO currently expects to fund the repurchase program from existing cash and cash equivalents, and future cash flows. The Company had approximately 671.6 million shares outstanding as of February 24, 2025.   This increased authorization, along with the prior authorization, represents approximately 14% of shares outstanding at the current stock price.

About
OPKO
Health

OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise, and its novel and proprietary technologies. For more information, visit www.opko.com.

Cautionary
Statement
Regarding
Forward
Looking
Statements

This
press
release
contains
“forward-looking
statements,”
as
that
term
is
defined
under
the
Private
Securities
Litigation
Reform
Act
of
1995
(“PSLRA”),
including,
among
other
things,
statements
related
to
expected
purchases
under
the
Repurchase
Program.
These
forward-
looking
statements
may
be
identified
by
words
such
as
“expects,”
“plans,”
“projects,”
“will,”
“may,”
“anticipates,”
“believes,”
“should,”
“intends,”
“estimates,”
and
other
words
of
similar
meaning.
These
statements
are
based
on
management’s
current
expectations
and
are subject
to
uncertainty
and
changes
in
circumstances.
Many
factors
could
cause
the
Company’s
actual
activities
or
results
to
differ
materially
from
the
activities
and
results
anticipated
in
forward-looking
statements.
These
factors
include
those
described
in
the
Company’s
Annual
Reports
on
Form
10-K
filed
and
to
be
filed
with
the
Securities
and
Exchange
Commission
and
under
the
heading
“Risk
Factors”
in
the
Company’s
other
filings
with
the
Securities
and
Exchange
Commission.
In
addition,
forward-looking
statements
may
also
be
adversely
affected
by
general
market
factors,
competitive
product
development,
product
availability,
federal
and
state
regulations
and
legislation,
the
regulatory
process
for
new
products
and
indications,
manufacturing
issues
that
may
arise,
patent
positions
and
litigation, among
other factors. The
forward-looking
statements
contained
in
this
press
release
speak
only
as
of
the
date
the
statements
were
made,
and
the
Company
does
not
undertake
any
obligation
to
update
forward-looking
statements.
The
Company
intends
that
all
forward-looking
statements
be
subject
to
the
safe-harbor
provisions
of
the
PSLRA.

Contacts:

Alliance Advisors IR

Yvonne Briggs, 310-691-7100
[email protected]
or
Bruce Voss, 310-691-7100
[email protected]

PHILADELPHIA, April 04, 2025 (GLOBE NEWSWIRE) — Carpenter Technology Corporation (NYSE: CRS) plans to host a conference call and webcast on Thursday, April 24, 2025 at 10:00 a.m. ET to discuss the results of operations for the third quarter of fiscal year 2025, ended March 31, 2025. The call and webcast will follow the release of third quarter fiscal 2025 financial results before the market opens on Thursday, April 24, 2025.

Conference Call and Webcast Details

What: Carpenter Technology Third Quarter Fiscal 2025 Conference Call

Date: Thursday April 24, 2025

Time: 10:00 a.m. Eastern Time

Live and Archived Webcast: ir.carpentertechnology.com

About Carpenter Technology

Carpenter Technology Corporation is a recognized leader in high-performance specialty alloy materials and process solutions for critical applications in the aerospace and defense, medical, transportation, energy, and industrial and consumer markets. Founded in 1889, Carpenter Technology has evolved to become a pioneer in premium specialty alloys including nickel, cobalt, and titanium and material process capabilities that solve our customers’ current and future material challenges. More information about Carpenter Technology can be found at www.carpentertechnology.com.

AUSTIN, Texas, April 04, 2025 (GLOBE NEWSWIRE) — Mondee Holdings, Inc. announces its acquisition by Tabhi, and exit from Chapter 11 restructuring. Tabhi acquired substantially all the assets of Mondee Holdings, Inc. and strengthened its balance sheet by investing additional equity, significantly reducing debt and other obligations.

Tabhi ownership includes affiliates of TCW Asset Management Company LLC (“TCW”), Morgan Stanley Investment Management (“MSIM”), and Prasad Gundumogula, the Company’s Co-Founder and Chairman. With a substantial personal cash investment, Mr. Gundumogula now holds a majority equity stake and has stepped in as the company’s CEO. TCW is also the Administrative Agent on a new credit facility that includes MSIM and Wingspire Capital LLC.

“The company is on stronger footing as we cut debt roughly in half, raised new cash equity, and have partnered with leading financial institutions,” said Mr. Gundumogula. “Now operating as Tabhi, the company is in a more stable financial and operational position to continue its prior growth as a leader in travel services and technology.”

Mr. Gundumogula continues, “We provide travel technology and privately negotiated airline and hotel content to over 65,000 travel experts and organizations who service over 125 million global travelers. The company was the first to introduce cutting edge AI in travel and we expect to continue to innovate and transform the industry with our AI solutions. With offices spanning four continents, we connect citizens of the world.”

About Mondee:

Established in 2011, Mondee is a leading travel marketplace and artificial intelligence (AI) technology company with its headquarters based in Austin, Texas. The Company operates 21 offices globally across the United States and Canada, Brazil, Mexico, India, and Greece. Mondee is driving change in the leisure and corporate travel sectors through its broad array of innovative solutions. Available both as an app and through the web, the Company’s platform processes over 50 million daily searches and generates a substantial transactional volume annually. Mondee Marketplace includes access to Abhi, one of the most powerful and fully integrated AI travel planning assistants in the market. Mondee’s network and marketplace include approximately 65,000 travel experts, 500+ airlines, and over one million hotels and vacation rentals, 30,000 rental car pickup locations, and 50+ cruise lines. The Company also offers packaged solutions and ancillary offerings that serve its global distribution. For further information, visit: www.mondee.com.

For Further Information, Contact:
Public Relations
[email protected]